Molecular Imaging: Page 47

NHS Scotland invests in prostate cancer imaging

By AuntMinnieEurope.com staff writers

National Health Service (NHS) Scotland plans to advance prostate cancer care by investing 2 million pounds (2.2 million euros) in PET imaging with the radiopharmaceutical gallium-68 and prostate-specific membrane antigen.

June 11, 2019

Hybrid imaging remains a mixed bag across Europe

By Wayne Forrest

Hybrid imaging practice is notably heterogeneous, training programs and qualification options are limited, and integrated, interdisciplinary PET/CT reporting is not implemented ubiquitously, a large European survey has found.

June 9, 2019

Jubilant DraxImage nets CE Mark for Rb-82 device

By AuntMinnieEurope.com staff writers

Radiopharmaceutical firm Jubilant DraxImage has received the CE Mark for its Ruby rubidium elution system and proprietary consumable accessories for the Ruby-Fill rubidium (Rb-82) generator.

June 6, 2019

DRG prepares to unveil book at 100th congress in Leipzig

By Philip Ward

The German Radiological Society (DRG) is to launch a new book about medical imaging's current and future role during the upcoming 100th German Radiology Congress (RöKo 2019), which begins in Leipzig on 29 May.

May 23, 2019

AIPES changes name to Nuclear Medicine Europe

By Leo Cendrowicz

The Association of Imaging Producers & Equipment Suppliers (AIPES) has changed its name to Nuclear Medicine Europe (NM-EU). The new name reflects the group's aims to represent industry's interests more effectively and improve its brand identity. The first president of NM-EU is Antonis Kalemis, PhD.

May 22, 2019

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

May 19, 2019

PET/CT ties ischemia risk to artery inflammation

By Wayne Forrest

PET/CT images are offering evidence of a link between vascular patterns at the time of diagnosis for giant cell arteritis and a patient's risk of an ischemic event, Spanish researchers explained in a study published online on 12 May in the European Journal of Nuclear Medicine and Molecular Imaging.

May 19, 2019

AI predicts myocardial infarction, death in patients at risk of CAD

By Erik L. Ridley

By analyzing clinical and hybrid imaging data, an artificial intelligence (AI) algorithm can predict which patients will go on to experience myocardial infarction or death during long-term follow-up, according to research from Finland presented at this week's International Conference on Nuclear Cardiology and Cardiac CT in Lisbon.

May 12, 2019

EANM pitches supplier audit project

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) is inviting companies involved in the manufacturing of PET radiopharmaceuticals to join its Shared Audit and Supplier Assessment Initiative.

May 7, 2019

ITM expands operations in Germany

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotopen Technologien München is set to increase its capacity to produce the medical isotope lutetium-177 at a facility in Neufahrn, Germany.

May 7, 2019

Blue Earth promotes presentations at AUA 2019

By AuntMinnieEurope.com staff writers

Molecular imaging firm Blue Earth Diagnostics is highlighting several presentations involving its Axumin (fluciclovine F-18) PET radiopharmaceutical and its "radiohybrid" prostate-specific membrane antigen (F-18 rhPSMA-7) imaging agent at the American Urological Association (AUA) annual meeting from 3-6 May in Chicago.

May 5, 2019

New breast CAD advances detection with MRI, PET

By Wayne Forrest

Researchers from Austria have developed a new computer-aided segmentation and diagnostic (CAD) algorithm to distinguish between cancerous and benign breast lesions using PET and MRI data. Their study was published online on 27 April in European Radiology Experimental.

May 2, 2019

Previous Page

Page 47 of 121

Next Page